Search Results - "HELLARD, M"

Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks by Hellard, M, Sacks-Davis, R, Doyle, J

“…[...]we consider barriers to treatment at the local level and how they could be overcome. [...]there are simple ways to interrupt transmission, such as the…”
Get full text

Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct‐acting antiviral agents by Olafsson, S., Tyrfingsson, T., Runarsdottir, V., Bergmann, O. M., Hansdottir, I., Björnsson, E. S., Johannsson, B., Sigurdardottir, B., Fridriksdottir, R. H., Löve, A., Hellard, M., Löve, T. J., Gudnason, T., Heimisdottir, M., Gottfredsson, M.

“…A nationwide programme for the treatment of all patients infected with hepatitis C virus (HCV) was launched in Iceland in January 2016. By providing universal…”
Get full text

Lives saved by public health restrictions over the Victorian COVID-19 Delta variant epidemic wave, Aug-Nov 2021 by Delport, D., Sacks-Davis, R., Abeysuriya, R.G., Hellard, M., Scott, N.

“…Prior to mid-2021, Australia’s approach to COVID-19 was to eliminate community transmission. However, between August-November 2021, the state of Victoria,…”
Get full text

HIV and Sexual Risk Among Men Who Have Sex With Men and Women in Asia: A Systematic Review and Meta-Analysis by Bowring, A. L., Veronese, V., Doyle, J. S., Stoove, M., Hellard, M.

“…We performed a systematic review to estimate the proportion of men who have sex with men (MSM) in Asia who are bisexual and compare prevalence of HIV and…”
Get full text

Constructing a ‘target population’: A critical analysis of public health discourse on substance use among gay and bisexual men, 2000–2020 by Schroeder, SE, Bourne, A, Doyle, JS, Hellard, ME, Stoové, M, Pedrana, A

“…BACKGROUNDGay and bisexual men (GBM) have higher substance use prevalences than general population samples - often attributed to stigmatisation of sexual…”
Get full text

Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia by Schroeder, Sophia E, Wilkinson, A L, O'Keefe, D, Bourne, A, Doyle, J S, Hellard, M, Dietze, P, Pedrana, A

“…Gay, bisexual and other men who have sex with men (GBMSM) are overrepresented in cohorts of people who inject drugs. GBMSM's substance use is usually explored…”
Get full text

HCV reinfection incidence among individuals treated for recent infection by Martinello, M., Grebely, J., Petoumenos, K., Gane, E., Hellard, M., Shaw, D., Sasadeusz, J., Applegate, T. L., Dore, G. J., Matthews, G. V.

“…Summary One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this analysis was to calculate the incidence of HCV…”
Get full text

Resumption of injecting drug use following release from prison in Australia by Winter, R.J, Young, J.T, Stoové, M, Agius, P.A, Hellard, M.E, Kinner, S.A

“…Highlights • 41% of 533 ex-prisoners with IDU history resumed IDU over 6 months after prison. • The highest incidence of IDU resumption occurred within 1 month…”
Get full text

A randomised controlled trial using mobile advertising to promote safer sex and sun safety to young people by Gold, J., Aitken, C. K., Dixon, H. G., Lim, M. S. C., Gouillou, M., Spelman, T., Wakefield, M., Hellard, M. E.

“…Mobile phone text messages (SMS) are a promising method of health promotion, but a simple and low cost way to obtain phone numbers is required to reach a wide…”
Get full text

Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond by Hellard, M., Scott, N., Sacks-Davis, R., Pedrana, A.

Get full text

Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct‐acting antiviral therapy for hepatitis C by Wade, A. J., McCormack, A., Roder, C., McDonald, K., Davies, M., Scott, N., Wardrop, M., Athan, E., Hellard, M. E.

“…Summary To increase access to treatment, the Australian government enabled general practitioners (GPs) to prescribe direct‐acting antivirals (DAAs) to treat…”
Get full text

Patterns and Characteristics of Hepatitis C Transmission Clusters among HIV-Positive and HIV-Negative Individuals in the Australian Trial in Acute Hepatitis C by Matthews, G. V., Pham, S. T., Hellard, M., Grebely, J., Zhang, L., Oon, A., Marks, P., van Beek, I., Rawlinson, W., Kaldor, J. M., Lloyd, A., Dore, G. J., White, P. A.

“…Background. Injecting drug users remain the population at greatest risk of acquiring hepatitis C virus (HCV) infection, although a recent increase in case of…”
Get full text

Letter: new treatments for hepatitis C have implications for quality of life in people who inject drugs by Higgs, P., Wright, C., Hellard, M.

Get full text

Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C: A systematic review by Shen, C., Dawe, J., Traeger, M.W., Sacks-Davis, R., Pedrana, A.E., Doyle, J.S., Hellard, M.E., Stoové, M

“…•Evidence for effectiveness of incentives to promote HCV care outcomes.•No randomised controlled trial assessed effectiveness of incentives for HCV…”
Get full text

Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia by Winter, R.J, Stoové, M, Degenhardt, L, Hellard, M.E, Spelman, T, Jenkinson, R, McCarthy, D.R, Kinner, S.A

“…Highlights • We calculated the incidence of non-fatal overdose among recently released prisoners. • Incidence was 27/100 person-years (PY) over 6 months…”
Get full text

Injecting drug use in low and middle‐income countries: Opportunities to improve care and prevent harm by O'Keefe, D., Stoové, M., Doyle, J., Dietze, P., Hellard, M.

“…Summary Inadequate response to injecting drug use (IDU) is a significant problem the world over. Low levels of funding, political inaction, poor levels of…”
Get full text

Towards realistic estimates of HCV incidence in Egypt by Breban, R., Doss, W., Esmat, G., Elsayed, M., Hellard, M., Ayscue, P., Albert, M., Fontanet, A., Mohamed, M. K.

“…Summary Accurate incidence estimates are essential for quantifying hepatitis C virus (HCV) epidemic dynamics and monitoring the effectiveness of public health…”
Get full text

Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia by Papaluca, T., O’Keefe, J., Bowden, S., Doyle, J.S., Stoove, M., Hellard, M., Thompson, A.J.

“…•Australian prevalence of baseline HCV GT1a NS5A RAS was 7%, lower than other countries.•The prevalence of NS5A RAS in GT1b and GT3 HCV is comparable to…”
Get full text

Prevalence of daily tobacco smoking participation among HIV‐positive and HIV‐negative Australian gay, bisexual and other men who have sex with men by Wilkinson, A, Quinn, B, Draper, B, White, S, Hellard, M, Stoové, M

Get full text

"I'm obviously not dying so it's not something I need to sort out today": Considering hepatitis C treatment in the era of direct acting antivirals by Wright, C, Cogger, S, Hsieh, K, Goutzamanis, S, Hellard, M, Higgs, P

“…People who inject drugs are the group at greatest risk of hepatitis C virus (HCV) infection. The advent of new direct-acting antiviral (DAA) treatment provides…”
Get full text